Back to Browse Journals » Substance Abuse and Rehabilitation » Volume 2 » Issue 1

Against professional advice: treatment attrition among pregnant methamphetamine users

Authors Lindsay B, Albrecht JS, Terplan M

Published Date October 2011 Volume 2011:2(1) Pages 189—195

DOI http://dx.doi.org/10.2147/SAR.S25083

Published 31 October 2011

Brianna Lindsay1, Jennifer Albrecht1, Mishka Terplan1,2
1Department of Epidemiology and Public Health, University of Maryland, 2Department of Obstetrics, Gynecology, and Reproductive Science, University of Maryland School of Medicine, Baltimore, MD, USA

Abstract: Pregnant methamphetamine users who leave substance use treatment against professional advice may be at risk of poorer health outcomes. To examine the hypothesis that methamphetamine use during pregnancy may be associated with leaving substance use treatment against professional advice, the 2006 Treatment Episode Data Set was analyzed. A logistic regression adjusting for age, race, service setting, prior substance abuse treatment, criminal justice referral, and education was conducted. Inclusion criteria were met by 18,688 pregnant admissions; 26.4% identified methamphetamines as their primary substance of use. Frequency of use was identified as an effect modifier, therefore results were stratified by less than weekly use and weekly or more use. Methamphetamine use was significantly associated with leaving treatment against professional advice regardless of usage level. However, the odds of leaving treatment were greater among women using methamphetamine less than weekly. Further investigation into this association may be warranted due to the complications that may result from methamphetamine use during pregnancy.

Keywords: pregnancy, methamphetamines, treatment, attrition

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Emerging options for the management of age-related macular degeneration with stem cells

Ingrid Mooney, James LaMotte

Stem Cells and Cloning: Advances and Applications 2011, 4:1-10

Published Date: 22 December 2010

Patterns and correlates of illicit drug selling among youth in the USA

Vaughn MG, Shook JJ, Perron BE, Abdon A, Ahmedani B

Substance Abuse and Rehabilitation 2011, 2:103-111

Published Date: 27 May 2011

A review of studies concerning treatment adherence of patients with anxiety disorders

Santana L, Fontenelle LF

Patient Preference and Adherence 2011, 5:427-439

Published Date: 23 August 2011

Drug use and self-medication among children with respiratory illness or diarrhea in a rural district in Vietnam: a qualitative study

Le TH, Ottosson E, Nguyen TKC, Kim BG, Allebeck P

Journal of Multidisciplinary Healthcare 2011, 4:329-336

Published Date: 13 September 2011

Osteogenic capacity of nanocrystalline bone cement in a weight-bearing defect at the ovine tibial metaphysis

Harms C, Helms K, Taschner T, Stratos I, Ignatius A, Gerber T, Lenz S, Rammelt S, Vollmar B, Mittlmeier T

International Journal of Nanomedicine 2012, 7:2883-2889

Published Date: 15 June 2012

Conformational changes of fibrinogen in dispersed carbon nanotubes

Park SJ, Khang D

International Journal of Nanomedicine 2012, 7:4325-4333

Published Date: 6 August 2012